Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;56(2):410-5.
doi: 10.1016/j.bone.2013.07.014. Epub 2013 Jul 19.

Effect of chronic kidney disease on the healing of titanium implants

Huawei Zou  1 , Xuefeng Zhao, Ningyuan Sun, Shiwen Zhang, Tadatoshi Sato, Haiyang Yu, Qianming Chen, Hans-Peter Weber, Michel Dard, Quan Yuan, Beate Lanske
Affiliations

Effect of chronic kidney disease on the healing of titanium implants

Huawei Zou et al. Bone. 2013 Oct.

Abstract

Chronic kidney disease (CKD) has become a worldwide public health problem. However, its effect on osseointegration of dental implants is largely unknown. The aim of this study is to investigate whether CKD impairs the quality of the osseointegration of titanium implants. Uremia was induced by 5/6 nephrectomy in mice, and serum levels of BUN, FGF23, PTH and ALP were significantly increased. For in vitro tests, bone marrow mesenchymal stem cells (BMMSCs) were obtained and cultured on titanium discs. There was no significant difference in term of expression of osteogenic marker genes including Osx, Col-1, Ocn, and Opn, as quantified by qPCR. Moreover, Alizarin Red S staining showed comparable mineralized nodules formation. Histomorphometrical analysis of experimental implants inserted in the femurs of CKD mice revealed a trend of decreased BIC ratio at 2-week healing. The strength of bone-implant integration, as measured by a push-in method, was significantly lower for the CKD group at 2 weeks, although a comparable level was reached at 4 weeks. These results demonstrated that CKD only negatively affects the osseointegration of titanium implants at the early stage.

Keywords: Bone mineralization; Chronic kidney diseases; Dental implants; Fibroblast growth factor 23 (FGF23); Osseointegration; Parathyroid hormone (PTH).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Illustration of the work flow and serum biochemical measurements. (A) Illustration of the work flow. (B) Serum BUN. (C) Serum FGF23. (D) Serum PTH. (E) Serum vitamin D. (F) Serum phosphate. (G) Serum calcium. *: p < 0.05.
Fig. 2
Fig. 2
Analysis of osteoblastic differentiation markers. (A) serum ALP activity. (B) ALP staining of cells seeded on titanium discs. (C) ALP staining of cells cultured on titanium discs. (D) Alizarin S staining of cells cultured on titanium discs. Gene expression of Osx (E), Col-1a (F), Opn (G) and Ocn (H). *: p < 0.05.
Fig. 3
Fig. 3
Implant surgery. (A&B) Experimental titanium implants. (C) Implant sites prepared in the distal end of femur. (D) Implant inserted into the distal end of femur. (E) X-ray examination of the femurs with implants.
Fig. 4
Fig. 4
Histology and biomechanical test. (A&B) Representative images of the histological sections at 2-week healing. (C) Bone-implant contact ratio at 2-week healing. (D&E) Representative images of the histological sections at 4-week healing. (F) Bone-implant contact ratio at 4-week healing. (G) Resistance of push-in tests. *: p < 0.05.
See this image and copyright information in PMC

References

    1. Saran R, Hedgeman E, Huseini M, Stack A, Shahinian V. Surveillance of chronic kidney disease around the world: tracking and reining in a global problem. Adv Chronic Kidney Dis. 2010;17:271–81. - PubMed
    1. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16:3736–41. - PubMed
    1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–59. - PubMed
    1. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–84. - PubMed
    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47. - PubMed